Business
Faron´s Annual Report 2021 Published
Faron´s Annual Report 2021 Published.
About this update from Faron Pharmaceuticals Oy
[{"type":"text","content":"\n \n \n \n RNS Number : 9829F\n Faron Pharmaceuticals Oy\n 25 March 2022\n \n \n \n \n Faron Pharmaceuticals Ltd\n \n \n (\"Faron\" or the \"Company\")\n \n \n \n \n \n Faron´s Annual Report 2021 Published\n \n \n \n \n \n \n \n \n Company announcement, 25 March 2022 at \n \n 9.15 AM (EET)\n \n \n \n / 07:15 AM (GMT) / 03:15 AM (EDT)\n \n \n \n \n \n \n \n \n TURKU, FINLAND / BOSTON, MA \n \n - Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, announces that its Annual Report for the year 2021 has been published today. \n \n \n \n \n \n Faron Pharmaceuticals´ Annual Report 2021 and audited financial statements for the accounting period 1 January - 31 December 2021 have been published in English and its financial statements in Finnish, on the Company's website \n \n \n https://www.faron.com/investors/results\n \n \n . \n \n \n \n \n \n http://www.rns-pdf.londonstockexchange.com/rns/9829F_1-2022-3-24.pdf\n \n \n \n \n \n \n \n For more information please contact:\n \n \n Media / Investor Contact\nFaron Pharmaceuticals\nEric Van Zanten\nHead of Communications\n \n \n \n [email protected]\n \n \n \n \n \n [email protected]\n \n \n \n \n Phone: +1 (610) 529-6219\n \n \n \n \n \n \n Cairn Financial Advisers LLP, Nomad\n \n \n \n \n \n Sandy Jamieson, Jo Turner\nPhone: +44 207 213 0880 \n \n \n \n \n \n Peel Hunt LLP, Broker \n \n \n Christopher Golden, James Steel\n \n \n Phone: +44 (0) 20 7418 8900 \n \n \n \n \n \n Sisu Partners Oy, Certified Adviser on Nasdaq First North\n \n \n Juha Karttunen\n \n \n Phone: +358 (0)40 555 4727\n \n \n Jukka Järvelä\n \n \n Phone: +358 (0)50 553 8990\n \n \n \n \n \n Consilium Strategic Communications\n \n \n Mary-Jane Elliott, David Daley, Lindsey Neville\n \n \n Phone: +44 (0)20 3709 5700\n \n \n E-mail: \n \n \n [email protected]\n \n \n \n \n \n \n \n \n \n \n \n \n \n About Faron Pharmaceuticals Ltd \n \n \n Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs caused...